Skip to main content

Chediak-Higashi Scientific Meeting coming up in November

All diseases have their milestones. This November is a big milestone for Chediak-Higashi Syndrome (CHS). 

For readers that might not know, CHS is a cousin disorder to HPS. It is another syndrome that involves albinism, although often the albinism is quite mild. Like HPS, people with CHS often have problems with the delta dense bodies on their platelets. CHS and HPS are both problems of protein trafficking. Those with CHS, however, have immune problems from birth on. Usually (though not always) these problems are quite severe and require one, if not several, bone marrow transplants. 

Thanks to bone marrow transplants, kids with CHS are living longer more often. Still, in early adulthood they tend to develop progressive neurological complications. 

Hermansky-Pudlak Syndrome is a rare disorder, but Chediak-Higashi Syndrome is even more rare. 

For many years the HPS Network has served as a defacto home for those with CHS. Sometimes they've been misdiagnosed with HPS first. Because our problems are so similar, we share many of the same researchers. We hope, however, that one day the CHS families will be able to organize and form their own group. 

For now, we are celebrating a huge milestone. 

The NIH is sponsoring a scientific symposium (Stonehouse) meeting to discuss issues surrounding recommendation of bone marrow transplants, as well as how to advance the research on the neurological issues of CHS. For the first time, 26 researchers from around the world will sit in one room for several days and talk about how to move towards better treatments for CHS. 

Now is a critical time. When they finish, we've got to keep the momentum going. They'll need funds raised to act as seed money for early research. They'll want to know that the CHS families are organized and willing to help in any way with their efforts. 

The sad fact is there are 7,000 rare diseases out there. Thousands of them would love to have NIH research, let alone an NIH-sponsored scientific meeting. 

To my many friends in the CHS world, congrads on your achievement! It'took lots of hard fundraising work and was a labor of love for your kids. Savor the moment, have a glass of wine, and get ready for the next steps! 

http://www.hpsnetwork.org/en/news/2013-11-03/nih-convenes-scientific-meeting-on-chediak-higashi-syndrome

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria